Statistics for Precision BioSciences (id:8354 DTIL)

Valuation metrics

Market cap

59.07M

Enterprise value

-8,912,843.00

Trailing P/E (ttm)

19.25

Forward P/E

-1.14

PEG ratio

-1.14

Price/Sales (ttm)

0.79

Price/Book (mrq)

0.89

Enterprise Value/Revenue

-0.12

Enterprise Value/EBITDA

0.74

Overview

Shares outstanding

7.67M

Float

6.19M

Shares short

214.55K

% Held by insiders

0.07%

% Held by institutions

0.43%

Average volume (10 days)

98.29K

Average volume (90 days)

Price summary

52-Week low

6.41

52-Week high

19.43

52-Week change

-58.26%

Beta

1.69

50-Day moving average

9.09

200-Day moving average

10.75

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

February 14th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

11.48%

Operating margin

-3,693.58%

Operational effectiveness

Return on assets

-6.38%

Return on equity

24.44%

Income statement

Revenue (ttm)

12.87

Revenue per share (ttm)

12.87

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-11,977,000.00

Net income to common (ttm)

11.48M

Diluted EPS (ttm)

0.40

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

101.20M

Total cash per share (mrq)

13.19

Total debt (mrq)

30.31M

Total Debt/Equity (mrq)

46.72

Current ratio (mrq)

922.40%

Book value per share (mrq)

8.67

Cash flow

Cash flow statement

-48,185,000.00

Levered free cash flow (LFCF)

4.09M